Minako Ishibashi
Overview
Explore the profile of Minako Ishibashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collins S, Lane S, Ishibashi M, Hamston T
Behav Ecol
. 2023 May;
34(3):418-425.
PMID: 37192927
Obtaining nesting material presents an optimal foraging problem, collection of materials incurs a cost in terms of risk of predation and energy spent and individuals must balance these costs with...
2.
Thomas C, Jalil A, Magnani C, Ishibashi M, Quere R, Bourgeois T, et al.
Atherosclerosis
. 2018 Jun;
275:409-418.
PMID: 29866392
Background And Aims: LPCAT3 plays a major role in phospholipid metabolism in the liver and intestine. However, the impact of LPCAT3 on hematopoietic cell and macrophage functions has yet to...
3.
Varin A, Thomas C, Ishibashi M, Menegaut L, Gautier T, Trousson A, et al.
Arterioscler Thromb Vasc Biol
. 2015 Apr;
35(6):1357-65.
PMID: 25838428
Objective: Liver X receptors (LXRs) modulate cholesterol and fatty acid homeostasis as well as inflammation. This study aims to decipher the role of LXRs in the regulation of polyunsaturated fatty...
4.
Kurosaki M, Kambe A, Ishibashi M, Watanabe T, Horie Y
Brain Tumor Pathol
. 2014 Jan;
31(3):187-91.
PMID: 24446079
We report a case of sarcomatous transformation of a prolactin (PRL)-producing pituitary adenoma in a 27-year-old man. He originally presented with bitemporal visual disturbance, headache, and hyperprolactinemia 8 years earlier....
5.
Ishibashi M, Sayers S, DArmiento J, Tall A, Welch C
Atherosclerosis
. 2013 May;
229(1):52-61.
PMID: 23676255
Objective: Inflammatory cell activation plays a key role in atherosclerotic plaque growth and acute complications. While secretion of proteases and inflammatory cytokines are likely involved in the development of plaque...
6.
Ishibashi M, Varin A, Filomenko R, Lopez T, Athias A, Gambert P, et al.
Arterioscler Thromb Vasc Biol
. 2013 Apr;
33(6):1171-9.
PMID: 23580142
Objective: Liver X receptors (LXRs) are oxysterol-activated nuclear receptors that are highly expressed in macrophages and regulate lipid homeostasis and inflammation. Among putative LXR target genes, lysophosphatidylcholine acyltransferase 3 (LPCAT3)...
7.
Ishibashi M, Filomenko R, Rebe C, Chevriaux A, Varin A, Derangere V, et al.
Biochem Pharmacol
. 2013 Jan;
86(1):122-9.
PMID: 23313547
Liver X Receptors (LXRs) α and β are oxysterol-activated nuclear receptors involved in the control of lipid metabolism and inflammation. Pharmacological activation of LXR is promising in the treatment of...
8.
Rebe C, Filomenko R, Raveneau M, Chevriaux A, Ishibashi M, Lagrost L, et al.
PLoS One
. 2012 Nov;
7(11):e48738.
PMID: 23185273
Background: Liver X receptor (LXR) α and LXR β (NR1H3 and NR1H2) are oxysterol-activated nuclear receptors involved in the control of major metabolic pathways such as cholesterol homeostasis, lipogenesis, inflammation...
9.
Ishibashi M, Masson D, Westerterp M, Wang N, Sayers S, Li R, et al.
J Lipid Res
. 2010 Jun;
51(9):2655-63.
PMID: 20562239
Niemann-Pick type C1 (NPC1) promotes the transport of LDL receptor (LDL-R)-derived cholesterol from late endosomes/lysosomes to other cellular compartments. NPC1-deficient cells showed impaired regulation of liver_X receptor (LXR) and sterol...
10.
Masson D, Koseki M, Ishibashi M, Larson C, Miller S, King B, et al.
Arterioscler Thromb Vasc Biol
. 2009 Oct;
29(12):2054-60.
PMID: 19815817
Objective: Increasing HDL levels is a potential strategy for the treatment of atherosclerosis. Methods And Results: ITX5061, a molecule initially characterized as a p38 MAPK inhibitor, increased HDL-C levels by...